checkAd
    Startseite > Aktien > Ocular Therapeutix > Nachrichten
    Ocular Therapeutix Aktie
    4,2730
     
    EUR
    -1,57 %
    -0,0680 EUR
    Letzter Kurs 08:07:34 Tradegate
    4,2010
     
    EUR
    1.500 STK
    Geldkurs 15:32:16
    4,2400
     
    EUR
    1.500 STK
    Briefkurs 15:32:16
    ISIN: US67576A1007 · WKN: A1180P · SYM: 0OT · USA

    Neueste Nachrichten

    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 18.04.2024
    18.04.24 · wO Chartvergleich · Exponent
    Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy
    18.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Strengthens Clinical Team with Appointment of Key Retinal Leaders
    16.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
    15.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
    09.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Announces Positive Phase 2 PAXTRAVA Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
    06.04.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
    26.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Fourth Quarter and Full Year 2023 Results
    11.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
    05.03.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
    22.02.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
    22.02.24 · globenewswire · Ocular Therapeutix
    Ocular Therapeutix Announces Board of Directors and Leadership Updates
    22.02.24 · globenewswire · Ocular Therapeutix